BiographyPaul Scherz began his academic career researching the genetics of embryonic development. After
completing a B.A. at U.C. Berkeley, a Ph.D. in Genetics at Harvard University, and a postdoctoral
fellowship at UCSF, he decided to investigate the theological and ethical implications of biomedical
research. He received an M.T.S. and a Ph.D. in Moral Theology from the University of Notre Dame.
Dr. Scherz researches the moral theology of biotechnology and medical practice. He uses the work of
Alasdair MacIntyre and Michel Foucault to examine how the daily use of biomedical technologies shapes
the way researchers, doctors, and patients see and manipulate the world and their bodies. His scholarly
interests also include Stoicism’s more general influences on Christian ethics, especially in the ars
moriendi tradition and end-of- life ethics, and understandings of risk in contemporary society as they
relate to emerging genetic technologies.
Scherz, P. (2017) Grief, Death, and Longing in Stoic and Christian Ethics. Journal of Religious Ethics 45(1):
Scherz, P. (2017) The Mechanism and Applications of CRISPR-Cas9 Gene Editing Technology. The
National Catholic Bioethics Quarterly 17(1): 29-36.
Scherz, P. (2017) Fragments of the Body in Christian, Bioethical, and Social Imaginaries. Studies in
Christian Ethics 30(4): 449-63.